Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Edison Wiesken"'
Autor:
Alphonse Ouédraogo, Alfred B Tiono, Désiré Kargougou, Jean Baptiste Yaro, Esperance Ouédraogo, Youssouf Kaboré, David Kangoye, Edith C Bougouma, Adama Gansane, Noelie Henri, Amidou Diarra, Souleymane Sanon, Issiaka Soulama, Amadou T Konate, Nora L Watson, Valerie Brown, Jenny Hendriks, Maria Grazia Pau, Isabella Versteege, Edison Wiesken, Jerald Sadoff, Issa Nebie, Sodiomon B Sirima
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78679 (2013)
Ad35.CS.01 is a pre-erythrocytic malaria candidate vaccine. It is a codon optimized nucleotide sequence representing the P. falciparum circumsporozoite (CS) surface antigen inserted in a replication deficient Adenovirus 35 backbone. A Phase 1a trial
Externí odkaz:
https://doaj.org/article/96190709ca5249a088f8c688c8a52167
Autor:
Jerald C. Sadoff, Edith C. Bougouma, Noelie Henri, Alfred B. Tiono, Souleymane Sanon, Sodiomon B. Sirima, Amidou Diarra, Valerie Brown, Amadou T. Konaté, Edison Wiesken, Alphonse Ouedraogo, Issa Nebie, Isabella Versteege, Désiré Kargougou, Jenny Hendriks, Issiaka Soulama, Nora L. Watson, Espérance Ouédraogo, Adama Gansané, Jean Baptiste Yaro, Youssouf Kaboré, David T. Kangoye, Maria Grazia Pau
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e78679 (2013)
PLoS ONE
PLoS ONE
Background Ad35.CS.01 is a pre-erythrocytic malaria candidate vaccine. It is a codon optimized nucleotide sequence representing the P. falciparum circumsporozoite (CS) surface antigen inserted in a replication deficient Adenovirus 35 backbone. A Phas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6989d41272ea4d0b675823a2adf7e61c
http://europepmc.org/articles/PMC3823848?pdf=render
http://europepmc.org/articles/PMC3823848?pdf=render
Autor:
Katarina Radosevic, Bregje Mommaas, Jaap Goudsmit, Stefan Kostense, Felicia Tirion, Mariska ter Haak, Jenny Hendriks, Edison Wiesken, Mariëlle Verhoeven, Maria Grazia Pau
Publikováno v:
Clinical and vaccine immunology, 18(5), 776-782. American Society for Microbiology
Various pre-erythrocyte malaria vaccines are currently in clinical development, and among these is the adenovirus serotype 35-based circumsporozoite (CS) vaccine produced on PER.C6 cells. Although the immunological correlate of protection against mal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fa256362530f5a7b77dcec9668e6e93
https://hdl.handle.net/1887/118917
https://hdl.handle.net/1887/118917
